Novel Protein Therapeutics Created Using the Elastin-Like Polypeptide Platform

Elastin-like polypeptides (ELPs) are bioengineered proteins that have a unique physical property, a thermally triggered inverse phase transition, that can be exploited for drug delivery. ELP-fusion proteins can be used as soluble biologics, thermally targeted drug carriers, self-assembling nanoparticles, and slow-release drug depots. Because of their unique physical characteristics and versatility for delivery of nearly any type of therapeutic, ELP-based drug delivery systems represent a promising platform for biologics development.

Automated summary

ELPs are bioengineered proteins with a unique physical property of a thermally triggered inverse phase transition, which can be utilized for drug delivery. ELP-fusion proteins have various applications, such as soluble biologics, thermally targeted drug carriers, self-assembling nanoparticles, and slow-release drug depots, making them a promising platform for the development of biologics.